| scholarly article | Q13442814 |
| P2093 | author name string | J. E. Fischer | |
| A. M. Ebeid | |||
| J. H. James | |||
| J. M. Keane | |||
| P. B. Soeters | |||
| H. M. Rosen | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatic encephalopathy | Q642548 |
| P304 | page(s) | 77-91 | |
| P577 | publication date | 1976-07-01 | |
| P1433 | published in | Surgery | Q15731526 |
| P1476 | title | The effect of normalization of plasma amino acids on hepatic encephalopathy in man | |
| P478 | volume | 80 |
| Q30978412 | (1)H nuclear magnetic resonance spectroscopy-based metabonomic study in patients with cirrhosis and hepatic encephalopathy. |
| Q35680475 | A Novel Multivariate Index for Pancreatic Cancer Detection Based On the Plasma Free Amino Acid Profile |
| Q90288369 | A multicentre clinical validation of AminoIndex Cancer Screening (AICS) |
| Q89723188 | A serendipitous voyage in the field of nutrition and metabolism in health and disease: a translational adventure |
| Q68194723 | Abnormal GH secretion in liver cirrhosis: evaluation of using GRF test and TRH test |
| Q39657117 | Adequacy and support of physiological functions in the acutely ill cirrhotic patient |
| Q24795177 | Agitation in the ICU: part one Anatomical and physiologic basis for the agitated state |
| Q38475804 | Albumin dialysis has a favorable effect on amino acid profile in hepatic encephalopathy |
| Q45092896 | Alterations in plasma and CSF amino acids, amines and metabolites in hepatic coma |
| Q39617054 | Amino acid derangements in patients with sepsis: treatment with branched chain amino acid rich infusions |
| Q48622343 | Amino acid, ammonia and neurotransmitter concentrations in hepatic encephalopathy: serial analysis in plasma and cerebrospinal fluid during treatment with an adapted amino acid solution |
| Q49014870 | Amino acids in hepatic coma |
| Q39815470 | Ammonia as an indicator of exercise stress implications of recent findings to sports medicine |
| Q41545796 | Analysis of Bioactive Amino Acids from Fish Hydrolysates with a New Bioinformatic Intelligent System Approach. |
| Q34547319 | Aromatic and branched-chain amino acids in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy |
| Q34856251 | Assessment of preoperative exercise capacity in hepatocellular carcinoma patients with chronic liver injury undergoing hepatectomy |
| Q70761248 | Augmented utilization of branched-chain amino acids by skeletal muscle in decompensated liver cirrhosis in special relation to ammonia detoxication |
| Q31079292 | Bench-to-bedside review: critical illness-associated cognitive dysfunction--mechanisms, markers, and emerging therapeutics |
| Q35059080 | Bolus ingestion of individual branched-chain amino acids alters plasma amino acid profiles in young healthy men |
| Q44656788 | Branched chain amino acid-enriched solutions in the septic patient. A randomized, prospective trial |
| Q39592418 | Branched chain amino acids in liver disease: fact or fantasy? |
| Q46047868 | Branched-chain Amino Acid Biosensing Using Fluorescent Modified Engineered Leucine/Isoleucine/Valine Binding Protein |
| Q38073719 | Branched-chain amino acids and muscle ammonia detoxification in cirrhosis |
| Q34495382 | Branched-chain amino acids in the treatment of chronic hepatic encephalopathy |
| Q42145047 | Branched-chain amino acids to tyrosine ratio value as a potential prognostic factor for hepatocellular carcinoma |
| Q48892613 | Branched-chain amino acids vs lactulose in the treatment of hepatic coma: a controlled study |
| Q40858134 | Can hepatic coma be caused by a reduction of brain noradrenaline or dopamine? |
| Q35807837 | Cerebral glucose metabolism after portacaval shunting in the rat. Patterns of metabolism and implications for the pathogenesis of hepatic encephalopathy |
| Q42120362 | Changes in brain ECF amino acids in rats with experimentally induced hyperammonemia |
| Q33599515 | Changes in human hepatic metabolism in steatosis and cirrhosis |
| Q48821311 | Changes in pituitary secretion after administration of branched-chain amino acids to patients with hepatic cirrhosis |
| Q28748632 | Characteristic metabolism of free amino acids in cetacean plasma: cluster analysis and comparison with mice |
| Q70451699 | Characteristics change in serum amino acid levels in different types of hepatic encephalopathy |
| Q37363068 | Circulating sterols as predictors of early allograft dysfunction and clinical outcome in patients undergoing liver transplantation |
| Q39690033 | Clinical pharmacological and therapeutic considerations in general intensive care. A review |
| Q44911805 | Combined renal and hepatic failure: The potential of serial hemodialysis and massive exchange plasmapheresis |
| Q70152864 | Comparison between neomycin and lactulose in 173 patients with hepatic encephalopathy: a randomized clinical study |
| Q28276168 | Comparison of distal and proximal splenorenal shunts: a randomized prospective trial |
| Q51647534 | Comparison of the effects of Hepatic-Aid and a Casein modular diet on encephalopathy, plasma amino acids, and nitrogen balance in cirrhotic patients. |
| Q81166495 | Controversies in ammonia metabolism: implications for hepatic encephalopathy |
| Q42726072 | Correction of altered plasma amino acid pattern in cirrhosis of the liver by somatostatin |
| Q39234270 | Correlation of plasma and brain amino acid and putative neurotransmitter alterations during acute hepatic coma in the rat |
| Q49309960 | Diagnostic and prognostic implications of plasma amino acid determinations in chronic active hepatitis |
| Q48413749 | Differentiation between the effects of unprocessed portal blood and reduced liver function on brain indole amine metabolism in the portacaval shunted rat. |
| Q67019029 | Diurnal variations in plasma neutral amino acid concentrations among patients with cirrhosis: effect of dietary protein |
| Q70920220 | Effect of L-dopa treatment on cerebral amino acid levels in rats after portocaval anastomosis |
| Q34533386 | Effect of branched chain amino acid infusions on body protein metabolism in cirrhosis of liver |
| Q43477094 | Effect of long-term oral supplementation with branched-chain amino acid granules on the prognosis of liver cirrhosis. |
| Q48111579 | Effects of a branched-chain amino acid-enriched diet on chronic hepatic encephalopathy in dogs |
| Q70332035 | Effects of branched chain amino acid infusion on glucose metabolism in cirrhotic patients with encephalopathy |
| Q48864363 | Effects of intraduodenal feeding of a branched-chain amino acid-rich solution on ammonia-induced encephalopathy in liver-injured rats. |
| Q74455762 | Evaluating response to nutritional therapy using the branched-chain amino acid/tyrosine ratio in patients with chronic liver disease |
| Q31135843 | Evidence of a vicious cycle in glutamine synthesis and breakdown in pathogenesis of hepatic encephalopathy-therapeutic perspectives |
| Q48625746 | Extra- and intracellular amino acids in the hippocampus during development of hepatic encephalopathy |
| Q93635906 | Flow- and pressure-adapted portal arterialization in dogs |
| Q72582902 | Hepatic encephalopathy: GABA or ammonia? |
| Q67349901 | Hepatic inactivation of vasoactive intestinal peptide in man and dog |
| Q34825710 | Hepatobiliary quiz 11 (2014) |
| Q37481692 | Hepatology - Guidelines on Parenteral Nutrition, Chapter 16. |
| Q39568662 | Hyperammonaemia, plasma aminoacid imbalance, and blood-brain aminoacid transport: a unified theory of portal-systemic encephalopathy |
| Q41634902 | Hyperprolactinemia in portal systemic encephalopathy |
| Q42709555 | Impaired gluconeogenesis in a porcine model of paracetamol induced acute liver failure. |
| Q48957485 | Impaired metabolism of methionine in severe liver diseases. II. Clinical and experimental studies on role of impaired methionine metabolism in pathogenesis of hepatic encephalopathy |
| Q39635412 | Increased immunoreactive vasoactive intestinal peptide in the cerebro-spinal fluid (CSF) of dogs and monkeys in hepatic failure |
| Q39341970 | Infusion of branched-chain enriched amino acid solution in patients with hepatic encephalopathy. |
| Q41722052 | Infusion of the Branched Chain Amino Acids in Postoperative Patients Anticatabolic Properties |
| Q30996686 | Integration of Genome-Wide SNP Data and Gene-Expression Profiles Reveals Six Novel Loci and Regulatory Mechanisms for Amino Acids and Acylcarnitines in Whole Blood |
| Q41277019 | Intra- and extracellular amino acid concentrations in portacaval-shunted rabbits. Role of hyperammonemia and effects of branched-chain amino acid-enriched parenteral nutrition |
| Q36012032 | Metabolic Characterization of Advanced Liver Fibrosis in HCV Patients as Studied by Serum 1H-NMR Spectroscopy |
| Q44175960 | Nutrition and liver failure |
| Q38371556 | Nutrition in the management of cirrhosis and its neurological complications. |
| Q72485088 | Nutritional Support in Liver Disease |
| Q36889702 | Nutritional support in acute intestinal failure |
| Q37375686 | Nutritional support in liver disease |
| Q35193845 | Nutritional support of the burned patient |
| Q40206760 | Nutritional support of the multiple trauma patient |
| Q47741783 | Oral supplementation with branched-chain amino acids improves survival rate of rats with carbon tetrachloride-induced liver cirrhosis |
| Q40264665 | Parenteral nutrition: current status and concepts |
| Q41022068 | Plasma Amino Acids as Predictors of the Severity and Outcome of Sepsis |
| Q70347519 | Plasma amino acid patterns in respiratory encephalopathy |
| Q66705137 | Plasma aminoacid imbalance in portal-systemic encephalopathy |
| Q34278911 | Plasma and cerebrospinal fluid amino acid patterns in hepatic encephalopathy. |
| Q67969954 | Plasma free amino acid pattern in chronic hepatitis as a sensitive and prognostic index |
| Q28740654 | Plasma free amino acid profiling of five types of cancer patients and its application for early detection |
| Q51655641 | Plasma neutral amino acid ratios in normal man and in patients with hepatic encephalopathy: correlations with self-selected protein and energy consumption |
| Q43996782 | Plasma-amino acid profiles in sepsis and stress |
| Q69995091 | Plasmaphoresis, charcoal, and resin perfusion in experimental porcine hepatic failure |
| Q40195497 | Portacaval shunts |
| Q49161564 | Portosystemic encephalopathy in two young dogs: some additional diagnostic and therapeutic considerations |
| Q38974984 | Profile of plasma amino Acid levels in rats exposed to acute hypoxic hypoxia |
| Q84183847 | Prognostic impact of preoperative the branched-chain amino acid to the tyrosine ratio in hepatocellular carcinoma patients after initial hepatectomy |
| Q40166336 | Progress in the treatment of chronic portasystemic encephalopathy |
| Q39697808 | Proline Metabolism in Sepsis, Cirrhosis and General Surgery The Peripheral Energy Deficit |
| Q33706732 | Protein tolerance to standard and high protein meals in patients with liver cirrhosis |
| Q47292838 | Ranges of phenotypic flexibility in healthy subjects |
| Q78250749 | Ratio of branched chain amino acid to tyrosine after hepatectomy |
| Q70335710 | Relationship of plasma amino acids to nitrogen balance and portal-systemic encephalopathy in alcoholic liver disease |
| Q28087493 | Reprint of: Nutrition in the Management of Cirrhosis and its Neurological Complications |
| Q88651382 | Serum Amino Acid Profiling in Patients with Alkaptonuria Before and After Treatment with Nitisinone |
| Q34474407 | Some clinical features of liver cell failure: an appraisal of their causes |
| Q38222142 | Statement on guidelines for total parenteral nutrition. The Patient Care Committee of the American Gastroenterological Association |
| Q28331136 | Successful use of vancomycin hydrochloride in the treatment of lactulose resistant chronic hepatic encephalopathy |
| Q92783462 | Systematic impacts of chronic unpredictable mild stress on metabolomics in rats |
| Q45797043 | T-type amino acid transporter TAT1 (Slc16a10) is essential for extracellular aromatic amino acid homeostasis control |
| Q40149898 | The Physiologic and Nutritional Significance of Plasma‐free Amino Acid Levels |
| Q34205897 | The dynamics of ammonia metabolism in man. Effects of liver disease and hyperammonemia |
| Q71972500 | The effects of intraportal prostaglandin E1 administration on hepatic warm ischemia and reperfusion injury in dogs |
| Q70871873 | The nature and prognostic significance of serial amino acid determinations in severe chronic active liver disease |
| Q80288173 | The present status of casualty care in Japan and the role of anesthesiologists |
| Q47548010 | The profiling of plasma free amino acids and the relationship between serum albumin and plasma-branched chain amino acids in chronic liver disease: a single-center retrospective study. |
| Q40260173 | The prospects for amino acid infusion |
| Q90648692 | The role of Branched Chain Amino Acids in the treatment of hepatic Encephalopathy |
| Q34587180 | The significance and robustness of a plasma free amino acid (PFAA) profile-based multiplex function for detecting lung cancer |
| Q48178855 | The turnover of brain monoamines after total hepatectomy in rats infused with branched chain amino acids |
| Q80288510 | Three approaches to pathophysiology of shock |
| Q41569675 | Total parenteral nutrition with F080 in cirrhotics with subclinical encephalopathy |
| Q53966426 | [Plasma amino acid concentrations and isoleucine-phenylalanine quotient in patients with acute myocardial infarct during amino acid infusion] |
Search more.